Abstract
A 48-year-old man with a history of Stage IV Diffuse Large B-Cell Lymphoma refractory to R-CHOP alternating with high-dose methotrexate and cytarbine, craniospinal irradiation, and haploidentical stem cell transplant, underwent CD 19-directed CAR-T.
Recommended Citation
Verghese, PGY-1, Danielle; Binder, MD, Adam; and Thomas, MD, Colin
(2020)
"Exploring the Adverse Effects of CAR-T Therapy: A Cases Report of Potential MINOCA in CAR-T,"
The Medicine Forum: Vol. 21, Article 11.
DOI: https://doi.org/10.29046/TMF.021.1.010
Available at:
https://jdc.jefferson.edu/tmf/vol21/iss1/11
